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Abstract
Background: Increased apposition of the frontal and parietal bones of the skull during embryogenesis may be a
risk factor for the subsequent development of premature skull fusion, or craniosynostosis. Human craniosynostosis is
a prevalent, and often serious embryological and neonatal pathology. Other than known mutations in a small number
of contributing genes, the aetiology of craniosynostosis is largely unknown. Therefore, the identification of novel genes
which contribute to normal skull patterning, morphology and premature suture apposition is imperative, in order to
fully understand the genetic regulation of cranial development.
Results: Using advanced imaging techniques and quantitative measurement, we show that genetic deletion of the
highly-conserved transcription factor Grainyhead-like 3 (Grhl3) in mice (Grhl3−/−) leads to decreased skull size, aberrant
skull morphology and premature apposition of the coronal sutures during embryogenesis. Furthermore, Grhl3−/− mice
also present with premature collagen deposition and osteoblast alignment at the sutures, and the physical interaction
between the developing skull, and outermost covering of the brain (the dura mater), as well as the overlying dermis
and subcutaneous tissue, appears compromised in embryos lacking Grhl3. Although Grhl3−/− mice die at birth, we
investigated skull morphology and size in adult animals lacking one Grhl3 allele (heterozygous; Grhl3+/−), which are
viable and fertile. We found that these adult mice also present with a smaller cranial cavity, suggestive of post-natal
haploinsufficiency in the context of cranial development.
Conclusions: Our findings show that our Grhl3 mice present with increased apposition of the frontal and parietal
bones, suggesting that Grhl3 may be involved in the developmental pathogenesis of craniosynostosis.
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Background
Increased apposition of developing bones in the skull is
an early event in the aetiology of craniosynostosis, the
pathological condition whereby cranial sutures fuse
prematurely. This may produce a spectrum of congeni-
tal deformities of the skull, and brain, and is estimated
to affect 1:2,000–1:2,500 live births [1–3]. Depending
on the pattern of affected sutures the resulting abnor-
malities may range from aesthetic anomalies to severe
neurological deficiencies and impaired cranial growth.
Craniosynostosis can occur as an isolated anomaly or
in conjunction with other congenital anomalies as part
of a syndrome. Syndromic cases of the common occur-
ring syndromes: Muencke, Crouzon, Apert and Pfeiffer
have been found to result from mutations of the FGFR
family of genes, where other anomalies of the skeleton
co-exist. The aetiology of most non syndromic cases re-
mains uncertain, but genetic mutations and epigenetic fac-
tors, including maternal drugs and diet are recognized [4].
Four major sutures exist in the mammalian skull,
termed the sagittal, metopic, coronal, and lambdoid, and
the correct temporal fusion of these is required to en-
sure that the embryonic and infant brain is able to grow,
and correctly develop, within the cranial cavity. Many
different combinations of anomalies affecting one or
more sutures have been described in humans. Bilateral
premature closure of the coronal sutures limits growth
in the sagittal plane and results in brachycephaly (a skull
shape shorter than typical for its’ species). Unilateral
premature closure of a coronal suture results in asym-
metrical distorted growth of the skull, termed plagioce-
phaly. The coronal suture is an embryologically unusual
suture because it is the site of neural crest derived
frontal bone and mesoderm derived parietal bone, and
as such presents as an interesting embryological study
of germ-layers and their derivatives. Defects in early de-
velopment, particularly the establishment of neural
crest-mesoderm interfaces at the suture boundary [5]
as well as defects in the overlying surface ectoderm or
underlying dura mater, may contribute to closer appos-
ition of the parietal and frontal bones and premature
coronal fusion.
Attempts to find specific genetic mutations resulting
in craniosynostosis have yet to fully uncover the mecha-
nisms by which premature suture fusion occurs in
humans. Our studies have revealed a gene which may be
a novel candidate for some of these conditions, the
highly conserved transcription factor Grainyhead-like 3
(Grhl3), a member of the Grainyhead-like genes essen-
tial for normal development [6]. Deletion of Grhl3 in
mouse (Grhl3−/−) results in neural tube defects [7],
mimicking the human pathology spina bifida, as well as
sporadic failed closure of the anterior neural tube, result-
ing in exencephaly in approximately 4 % of cases. This
condition is exacerbated in embryos which lack both
Grhl3 and the related family member Grhl2, whereby
embryos present with fully penetrant failure of anterior
neural tube closure [8]. Grhl3−/− embryos also fail to
develop a functioning epidermal barrier, and die im-
mediately post-natally from trans-epidermal water loss
and resulting dehydration [9]. Furthermore, Grhl3−/−
embryos also present with numerous other surface
ectoderm defects, namely defective wound healing and
impaired cellular migration [10, 11], predisposition to
squamous-cell carcinoma [12], as well as defective
convergence-extension mediated migration [7], resulting
in shorter, fatter embryos.
Here we present novel observations of the skull of
Grhl3−/− embryos, as well as adult Grhl3+/−mice, which
reveal that loss of Grhl3 results in impaired skull forma-
tion, and closer apposition of the parietal and frontal
bones, with concomitant premature osteoblast alignment
and organisation in embryos, and decreased cranial vault
size in adults. Although important to note that we do
not observe actual premature fusion of the frontal and
parietal bones, due to embryonic lethality at E18.5, our
observations indicate that loss of Grhl3 is a novel genetic
model of closer apposition of the parietal and frontal
bones. These data suggest the possibility that abrogation




All animal experiments were pre-approved by the
Alfred-Monash University Research and Education Pre-
cinct (AMREP) Animal Ethics Committee (AEC), project
#E1200/2012/M. For embryological analyses, Grhl3+/−
mice were intercrossed, and detection of a vaginal plug
was designated as embryonic day (E) 0.5. Embryos were
collected at day 18.5 post fertilisation (E18.5), and eutha-
nased by decapitation. In order to examine skulls from
adult Grhl3+/− mice, adults were euthanased by CO2
administration. All animals were maintained on a C57/Bl6
background for a minimum of 24 generations, and female
embryos/adults were used to both exclude the possibility
of confounding hormonal influences on suture fusion/
skull development, as well as to minimise the number of
adult mice required.
Micro X-ray computed tomography
Micro X-ray Computed Tomography (μXCT) measure-
ments were conducted using an Xradia© micro XCT200
(Carl Zeiss X-ray Microscopy, Inc., USA). This uses a
microfocus X-ray source with a rotating sample holder
and an imaging detector system. The source consists of
a closed X-ray tube with the tube voltage of 40 kV and a
peak power of 10 W. One data acquisition set contained
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361 equiangular projections over 180° providing a complete
tomographic reconstruction. The exposure time was 8 s for
each projection. The tomographic scan involved rotating
the sample whilst recording transmission images on the
charge-coupled device (CCD). Each projection image was
corrected for the non-uniform illumination in the imaging
system, determined by taking a reference image of the
beam without sample. A filtered back-projection algorithm
(TXM Reconstructor, Carl Zeiss X-ray Microscopy, Inc.,
USA) is used to obtain the 3D reconstructed image.
The final three-dimensional reconstructed image size
was 512 × 512 × 512 voxels. Two different set-ups were
used in this study:
1. The first set-up was used to acquire the embryo
samples, with an effective voxel size of 31 μm×
31 μm× 31 μm and a Field of View (FOV) of
16 mm × 16 mm × 16 mm.
2. The second set-up was to acquire adult female skull
samples (n = 8 WT and n = 11 Grhl3+/−) with an
effective voxel size of 67 μm along each side and
a FOV of 34 mm along each side.
We used the Avizo-6.2 software (Mercury Computer
Systems Inc., France) for image segmentation of the
embryo samples and TXM3DViewer (Carl Zeiss X-ray
Microscopy, Inc. USA) for the 3D visualization and
measurements. Measurements of the skull were made
to find the maximum sagittal length of the skull from
the tip of the nasal bones to the occiput, as well as
the maximum sagittal length, height and width of the
cranial cavity.
2D images of E18.5 embryos (n = 4 WT and n = 4
Grhl3−/−) generated with the software to show the
frontal and parietal bones from above were analysed
to measure coronal suture area using ImageJ software
[13]. Statistical analysis of measurements (Student’s
T-Test) was performed using Prism GraphPad (San
Diego, CA, USA).
Morphometric quantitation of skull morphology
Skull landmarks used for quantitative analyses were as
reported previously [14]. In brief, we utilised 7 of these
landmarks for our measurements, these were: (1) Most
anterior point of the nasal bone, medial region (mnsla),
(2) Most superior point on the squamous temporal,
intersection of the coronal suture, left side (lsqu), (3)
Mid-point on the posterior margin of the foramen mag-
num, taken on squamous occipital (opi), (4) Most medial
intersection of the frontal and parietal bones, taken on
the parietal, left side (lfpi), (5) Most inferior portion of
the cranial vault (cvi), (6) Most posterior point on the
posterior extension of the forming squamosal, right side
(rpsq), (7) Most posterior point on the posterior exten-
sion of the forming squamosal, left side (lpsq).
Cartilage and bone histology
Heads from E18.5 mouse embryos were prepared for
staining by fixation in 4 % Paraformaldehyde (PFA), dec-
alcified in a solution of 10 % EDTA (w/v) for 24–48 h,
and processed using standard histological procedures.
Samples were then embedded in paraffin, and 8 μm sec-
tions were cut for all subsequent stains. Adult skulls
were decalcified in 10 % EDTA (w/v) for 96–120 h.
Alcian Blue (cartilage) and Alizarin Red (bone) staining
[7], light dissection microscope imaging [15] and all
other histological stains [16] were conducted as de-
scribed previously.
Immunohistochemistry
All Immunohistochemistry experiments were conducted
using either 4 % PFA or formalin-fixed, paraffin-embedded
tissue, processed and stained using standard methods,
as described previously [12, 17]. The antibodies used
were FGFR1 (My Biosource; cat# MBS9209911),
pFGFR1 (Abcam; ab59194), FGFR2 (My Biosource; cat#
MBS821068), Noggin (Abcam, ab16054), Twist (Santa
Cruz, sc-6269), and Runx2 (Abcam; ab23981), using stand-
ard histological methods [12, 17] and according to the
manufacturer’s recommendations.
Results
Loss of Grhl3 leads to gross morphological defects and
closer apposition of frontal and parietal bones in the
E18.5 embryonic skull
In order to assess gross developmental phenotypes,
E18.5 embryos were collected and viewed by dissecting
microscopy. Viewed both laterally (Fig. 1a, b) and dor-
sally (Fig. 1c, d) the Grhl3−/− embryos were noted to
have flattened foreheads, elevated, angulated orbital rims
and a widened, flatter snout in comparison to control,
(wild-type; WT) littermates. Defects in skull morphology
were also readily observable following skeletal staining
(Fig. 1e, f ). Overall, the heads of Grhl3−/− embryos ap-
peared shorter, and displayed features highly consistent
with human brachycephaly.
In order to more closely examine the ultrastructure of
the skull, further analysis of the cranial bones was con-
ducted by skeletal staining. When viewed laterally, a
clear demarcation between the frontal and parietal bones
at the coronal suture could be seen in WT embryos.
The distinction between the two skull bones was less ap-
parent in the Grhl3−/− embryo which appeared more flat
superiorly. Having dissected the caudal half of the skull
from the cranial half to allow clear views of the coronal
suture from above we could demonstrate a clear boundary
of non-calcified tissue between the frontal and parietal
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Fig. 1 Loss of Grhl3 leads to premature suture fusion and aberrant skull morphology in E18.5 mouse embryos. a-d Dissecting light microscopy
images showing shortened and flattened skull morphology, lack of suture vascularisation and decreased skull size in Grhl3−/− embryos (b, d)
compared to WT (a, c) at E18.5. a, b shown in lateral view, C-D in dorsal view. e-h Alcian Blue/Alizarin red staining of WT (e, g) and Grhl3−/− (f, h)
embryos in lateral (e, f) and dorsal (g, h) views, highlighting skull morphology and suture development. i, j High-powered images of the boxed
region in (g, h), showing a clearly open suture in WT embryos (i), and a fused suture in Grhl3−/− embryos (j)
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bones in the WT, while this was qualitatively less appre-
ciable in the Grhl3−/− (Fig. 1g, h). Magnification of the
coronal suture highlighted this boundary further in WT
while the Grhl3−/− mice presented with a continuum of
tissue extending across the suture (Fig. 1i, j). Taken to-
gether, these data indicate that loss of Grhl3 impacts on
skull shape, size and apposition of the frontal and parietal
bones.
Micro CT analyses indicate significant differences in
cranial dimensions of Grhl3−/− E18.5 embryos
Micro CT allows extremely accurate imaging of the skull
bones, even in the relatively undeveloped E18.5 embryo.
We performed detailed measurements of both embry-
onic and adult female mouse skulls, using morphometric
landmarks described previously ([14], see methods) and
generated images of the skull with the caudal sections
removed digitally, allowing clear visualisation of the
frontal and parietal bones and measurement of the cor-
onal suture area (Fig. 2a–f; see also 3D rotating movies
in Additional file 1: Figure S1). Analyses of the Micro
CT measurements showed statistically significantly re-
duced total sagittal length of the skull, cranial length,
cranial width and cranial height in the Grhl3−/− embryos
compared to the WT controls (Fig. 2g–k). No statistically
significant differences were seen in the size of the occipital
bone (data not shown). Facial skeleton lengths were also
not significantly different between groups, suggesting the
overall shortage in skull length was from the shorter cra-
nial length. Measuring coronal suture area on both sides
of each embryo (n = 8 WT and n = 8 Grhl3−/−) revealed a
significant reduction in open suture area in the Grhl3−/−
embryos compared to their WT littermates, suggesting
greater levels of calcification in the Grhl3−/− sutures. Com-
pensatory widening of the sagittal suture was seen in 50 %
of the embryos, as is often the case in human bicoronal
craniosynostosis. These measurements allowed us to
quantitatively demonstrate suture openings in the
Grhl3−/− embryos, and further support the hypothesis
of closer apposition of frontal and parietal bones.
Grhl3−/− E18.5 embryo skulls present with organised
collagen deposition and premature osteoblast alignment,
although expression of known genes involved in
craniosynostosis is largely unchanged
In order to examine whether the sutures of Grhl3−/− em-
bryo skulls displayed histological and molecular hallmarks
of a predisposition to premature suture fusion, we firstly ex-
amined coronal sections using traditional histological stains
(Verhoeff ’s van Gieson’s, Masson’s Trichrome, Toluidine
blue and Von Kossa stains), which remain both the simplest
and clearest method of demonstrating the developing su-
tures. Sagittal sections of skull from WT and Grhl3−/− E18
embryos were stained and compared. Osteogenic fronts of
the coronal and lambdoidal sutures normally overlap as
they develop, whereas the other sutures about each other
before fusing. Type I collagen is the main structural protein
in developing bone. It provides the extracellular matrix
(ECM) or “scaffold” on which the cellular components of
developing cartilage and bone can anchor and gain context-
ual signals for proliferation and differentiation. Verhoeff ’s
van Gieson’s stain highlights collagen as red/pink in histo-
logical sections. We saw little evidence of organised colla-
gen deposits at the location of the coronal suture in WT
E18 embryos, however, in the Grhl3−/−embryos, clearly
overlapping areas of organised collagen can be seen (Fig. 3a,
b). Next, we used Masson’s trichrome stain to detect oste-
oid (developing) bone (which stains red) as well as existing
bone (blue). Our data show that the bone profile in WT
embryos showed diffuse blue and red staining in the region
of the developing coronal suture, whereas the Grhl3−/−
skulls demonstrated clear overlapping projections of blue
staining, suggesting this bone was further mineralised than
in the WT controls (Fig. 3c, d). Next, we employed
Toluidine blue staining to clearly demarcate the cellular
components of newly developing bone, particularly os-
teoblasts. In our E18 embryo sections, little evidence of
organised cell behaviour was visible in the WT skulls,
however, in the Grhl3−/− animals, the developing osteoid
stained dark blue nuclei, to define a clear row of osteo-
blasts along the emerging front (Fig. 3e, f ). Lastly, we used
Von Kossa staining to distinguish cartilage from calcified
bone, however we could detect no difference in WT and
Grhl3−/− embryos (data not shown), suggesting that the
premature fusion we see is not due to hyper-calcification
of the skull. Similar analyses of E18.5 WT, Heterozygous
(Grhl3+/−) and Grhl3−/− embryo skulls similarly did not
detect any significant differences in mineralisation, colla-
gen deposition or osteoblast alignment between WT and
Grhl3+/− skulls (Additional file 2: Figure S3).
Previous work had shown that the dura mater, the
outer-most membrane enveloping the brain and spinal
cord, is critical for the regulation of spatiotemporal cra-
nial suture fusion, putatively through the secretion of
paracrine factors [18–20]. We noted in our histological
sections that in the majority of WT (and also Grhl3+/−,
not shown) embryos examined, the cerebrum, and there-
fore dura mater, is clearly visible in close proximity to
the bones of the developing skull (Fig. 3a, c, and e).
Similarly, the overlying dermis and subcutaneous tissue
in WT and Grhl3+/− skulls was clearly visible in close
contact in our histological sections. However, we noted a
significant disconnect between the generally underdevel-
oped cerebrum and the skull in all Grhl3−/− embryos, in-
dicating that the dura mater may not make strong
physical contact with the overlying bone (Fig. 3b, d, f );
furthermore, we also noted a disconnect in apposition be-
tween the overlying dermis and the skull. These results
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suggest that decreased dorso-ventral tensile strength be-
tween both the overlying dermis, and underlying dura,
may partially underpin the differential (closer) apposition
of frontal and parietal bones seen in Grhl3−/− mice.
Lastly, in order to determine whether aberrant regulation
of genes known to be involved in the aetiology of cranio-
synostosis underpinned any of the defects we observed, we
examined the expression of Noggin, FGFR1/pFGFR1,
FGFR2, Runx2 and Twist1 by immunohistochemistry (see
methods). Save for a potential loss-of-expression of pFGFR1
in the suprabasal epidermal layers of Grhl3−/− mice, we
could detect no significant differences in expression of any
of these factors in the developing sutures, dermis or dura
mater in Grhl3−/− embryos, at either E16.5 (Additional file
3: Figure S4a-b) or E18.5, (Additional file 4: Figure S5a-b),
indicating that aberrant expression or localisation of
these factors is unlikely to account for the phenotypes
we observe.
Fig. 2 Loss of Grhl3 leads to significant differences in skull length and width. a-d Schematic diagrams on WT skulls showing measurements taken
using Micro CT analysis. Micrographs highlighting the morphometric landmarks utilised for quantitative analyses, shown in sagittal (a) and ventral
(b) views (see methods for details). Representative diagrams showing measurements taken, namely sagittal length (1–3), cranial vault length (2–3)
and width (6–7), and cranial height (4–5; c, d). e, f Representative 2D images generated of the skull with the caudal sections removed digitally,
allowing clear visualisation of the frontal (f) and parietal (p) bones, and the suture between them. (g-k) Quantitation of measurements of regions
outlined in (a-d), namely maximal sagittal length (g), cranial length (h), maximal cranial width (i), cranial height (j), and the open suture area (k) in
WT and Grhl3−/− embryos. *p < 0.05; **p < 0.01; ***p < 0.005
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Heterozygous loss of Grhl3 leads to defects in skull size,
but not premature suture fusion, in adult mice
As noted, the Grhl3−/− embryos are lethal at birth; we
were therefore unable to analyse cranial morphology
and suture fusion in these mice post-natally. However,
Grhl3+/− mice (both adults and embryos) present with
no observable phenotypic defects, and are both viable
and fertile. Previous analysis of both Grhl2 and Grhl3
function in a variety of animal models, both by us and
others, clearly indicates that animals with compromised,
but still present, Grhl3 function (termed “altered gene-
dosage”) present with a spectrum of phenotypic defects
[8, 21–23]. An example of a hypomorphic Grhl3
phenotype is the “curly-tail” mutant, in which a small
proportion of mice present with a curled-tail and sacral
spina bifida due to a mutation in an upstream Grhl3
regulatory element [24, 25]. Additionally, the homeostatic
roles played by this family are often not apparent until
later in life, as is the case with Grhl2 loss ultimately lead-
ing to age-related hearing impairment [26]. Lastly, human
craniosynostosis itself presents as a spectrum of pene-
trance and severity of the condition. The subtler deform-
ities may not require intervention, or even be clinically
apparent, without careful radiological examination.
Taking these factors into account, we examined the
skulls of adult WT and Grhl3+/− skulls, in order to care-
fully examine suture formation and cranial size. Our
gross examinations did not elucidate any obvious abnor-
malities of the coronal suture or other features (Fig. 4a,
b). Using Micro CT, we examined the skulls in order to
determine whether subtle defects were present in our
heterozygous mouse population, however comparing Micro
Fig. 3 Premature collagen deposition, mineralisation and osteoblast alignment are seen in E18.0 Grhl3−/− embryos (a, b) Verhoeff’s van Gieson’s
(collagen) stain showing little evidence of organised collagen deposits at the location of the coronal suture in WT embryos (a), in contrast to
Grhl3−/−embryos (arrowheads, b). c, d Masson’s trichrome stain showing diffuse staining in the region of the developing coronal suture in WT
embryos (c), compared to overlapping projections of blue staining (indicative of increased mineralisation) in Grhl3−/− (arrowheads, d). e, f Toluidine
blue staining showing dark blue nuclei to define a clear row of osteoblasts along the emerging front in Grhl3−/− embryos (red arrows, f); these were
not noticeable in WT embryos (e). Inset (boxed) regions in all panels show increased magnifications of the embryonic skull. Note that the dura mater
(DM) and underlying cerebrum are in clear contact with the skull in WT (a, c, e) but not Grhl3−/− (b, d, f) embryonic skulls
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CT generated images of the skulls both in dorsal (Fig. 4c, d)
and lateral (Fig. 4e, f) planes did not demonstrate any sig-
nificant differences (also see movies in Additional file 5:
Figure S2). Quantitative measurements of the maximum
sagittal length of the skulls showed no significant difference
(Fig. 4g), however, Grhl3+/− mice showed a small but statis-
tically significant difference in the length of the cranial cav-
ity (Fig. 4h). Cranial cavity width and height were not
statistically different between the two groups (data not
shown). Together, these data indicate that Grhl3 het-
erozygosity impacts on the size of the cranial cavity,
but not suture fusion.
Discussion
Craniosynostosis is a relatively common congenital de-
formity affecting the human skull, underpinned by (e.g.)
a closer apposition of the frontal and parietal bones.
Following the observation that Grhl3−/− embryos
present with a grossly abnormally skull shape and
smaller size than WT littermates, we investigated this
phenotype further using Micro CT, and found differences
in overall skull length, as a consequence of reduced cranial
cavity length. Cranial height and width were also signifi-
cantly reduced in the Grhl3−/− embryos. Histologically, we
detected an increased collagen framework deposition in
Fig. 4 Adult skull analysis in Grhl3 heterozygous (Grhl3+/−) mice (a, b) Light microscopy showing no significant difference in suture size, width
between WT (a) and Grhl3+/− (b) skulls. c-f Micro CT images showing skulls of both WT (c, e) and Grhl3+/− (d, f) adult mice, in dorsal (c, d) and
lateral (e, f) views. g, h Quantification of skull size shown no significant difference (p = 0.57) in the maximum sagittal length (g), but a statistically
significant reduction in cranial length (h) between WT and Grhl3+/−skulls. *p < 0.05
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the coronal suture of the Grhl3−/− embryos at E18. The
Grhl3−/− mice coronal sutures also showed a greater de-
gree of mineralisation and organisation of osteoblasts.
Interestingly, although not grossly abnormal, the skulls of
adult Grhl3+/− mice were statistically shorter in terms of
length of the cranial compartment, a phenotype which
may perhaps mirror some of the sub-clinical human pre-
sentations. Our data indicate that Grhl3−/− mice are a
novel model for intrauterine events leading to the in-
creased apposition of calvarial bones, and our future work
will be focused on identifying the underlying genetic
mechanisms which underpin this phenotype.
Skull defects in our model are highly consistent with the
overall shortened, squat stature of embryos lacking Grhl3,
due to decreased convergence-extension movements, al-
though interestingly these mice are technically not
“smaller”, as the size of other skeletal components, such
as the overall length of the spine or limbs, are not signifi-
cantly smaller in Grhl3−/− embryos [7]. These data suggest
that head and skull size, as well as suture apposition, may
be regulated by cranial-specific Grhl3 function. Our previ-
ous histological examinations characterising the expres-
sion of Grhl3 by in situ hybridisation did not identify
expression at the coronal suture site, or within the skeletal
precursor cells themselves [27], save for a thin band of ex-
pression visible in the anterior-most neurocranium, over-
lying the olfactory epithelium [7]. However, the expression
of Grhl3 in this region is unlikely to account for the closer
apposition of the frontal and parietal bones or decreased
skull size we observed. More likely, epithelial extension
defects in the overlying surface ectoderm (where Grhl3 is
robustly expressed) lead to secondary defects in the as-
sembly, expansion and temporal regulation of skull devel-
opment and fusion, whereby the skull is compressed due
to decreased availability of space in which to grow.
Closer apposition of future suture sites may lead to
premature fusion, as seen in craniosynostosis. Genetic
deletion of factors in the epidermis has previously been
described to result in defective formation of underlying
bone. Deletion of the transcription factor IRF6 (itself an
upstream regulator of Grhl3; [28]), resulted in significant
skin tightening in the limb buds, to the point where the
underlying digits are deformed and the limb buds
remained as “stumps” [29], whereas deletion of the IkB
kinase-a (IKK-α) led to significant craniofacial defects,
which interestingly, could be rescued upon restoration
of IKK-α re-expression within the epidermis [30]. These
data suggest that genetic defects during development may
manifest through a putative disruption of epidermal-
mesodermal, or epidermal-neural crest interactions,
resulting in subsequent patterning and morphogenesis of
the bone.
A second possibility pertains to a disruption to the
identity and fate of the neural crest. Although the coronal
suture progenitor cells are generally thought to be Sonic
hedgehog (Shh)-responsive cells of paraxial mesodermal
origin [31, 32], the frontal bone itself is largely neural-
crest derived, suggesting that mislocalisation of the neural
crest within the boundary may contribute to defective es-
tablishment of a clear demarcation (boundary) at the
neural-crest/mesoderm interface of the future frontal/par-
ietal suture. This precise phenotype has in fact been de-
scribed previously in the context of disrupted Ephrin-Eph
signalling downstream of aberrant Msx2 or Twist1 signal-
ling [5]. Coupled with a recent study showing that Grhl3
is expressed at the neural plate/non-neural ectoderm
border, the site of future neural crest cell delamination
and migration [33], one could imagine that a failure in in-
structional cues governing neural crest cell fate, particu-
larly a shift in the signals required for maintenance of
positioning at the suture interface, may contribute to some
of the subsequent patterning and morphological defects
we observe, Our current studies are aimed at addressing
which of these mechanisms is likely to underpin the closer
apposition of the frontal and parietal bones we observe in
Grhl3−/− embryos, particularly by investigating the cell-
intrinsic role played by Grhl3 within the neural crest,
closer investigation of Ephrin-Eph signalling in the early
stages of embryogenesis, putative links between Shh and
grhl3 [34], and modelling grhl3 deletion in the surface
ectoderm (and subsequent skull development) using the
highly tractable zebrafish model system.
Further supporting our model that the closer appos-
ition of the frontal and parietal bones we observe is sec-
ondary, rather than primary (i.e. cell autonomous), is
previous evidence regarding the important role played
by the dura mater on maintaining cranial sutures. Previ-
ous transplant experiments [35, 36] examined the re-
quirement of the dura mater in the development and
maintenance of the normally patent coronal suture by
transplanting coronal suture complexes with or without
dura mater from E19 and P1 rats to attempt rescue of
parietal defects in adult rats. In the absence of dura
mater, the coronal suture was fused prematurely by
3 weeks after transplantation, whereas in the presence of
dura mater, the coronal suture remained open. The
mechanisms for regulation were thought to be a secre-
tion of necessary paracrine factors, particularly members
of the FGF, IGF and TGFβ families of mitogens [37–40]
from the dura mater to the osteoblasts of the developing
sutures. Although we have not detected expression of
Grhl3 in the dura mater [27], and therefore a dura-spe-
cific defect is unlikely, we speculate that the reduced adhe-
sive strength between the dura and cranial suture sites,
resulting from defective convergence-extension as dis-
cussed above, may also be a contributing factor to
the closer apposition of the frontal and parietal bones
we observe.
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As Grhl3 functions as a transcription factor, whose
role is to activate or repress the expression of target genes
through direct binding to promoter or enhancer se-
quences, we also investigated putative regulatory mecha-
nisms which may contribute to our observed phenotype.
We had previously generated a list of 305 candidate target
genes, based on alignment of gene promoters across pla-
cental mammals, and interrogating these for the presence
of the conserved Grhl-family binding site, broadly
AACCGGTT (with the first “C” and second “G” invariant).
Our group has previously identified numerous genes from
this list as true Grhl-target genes, including Tgm1 [9],
Dsg1 [41], PTEN [12], RhoGEF19 [10], eng2a and spec1
[21], edn1 [22] and GSK3β [17]. From this list, we identi-
fied another potential candidate, FGFR1. Mutations in the
FGFR family are known to cause craniosynostosis in vari-
ous human syndromes [42], largely through an aberrant
balance between apoptosis and proliferation of suture
cells, making FGFR1 a logical potential target for investi-
gation of the mechanism causing craniosynostosis in our
model. However, neither our immunohistochemistry ex-
periments, or qPCR of suture tissue dissected from Grhl3
embryos (data not shown) detected a significant difference
in expression between WTand Grhl3−/− embryos in either
the dura, calvaria or the suture site. Interestingly, we did
note an apparent decrease of activated pFGFR1 in the
most superficial layers of the epidermis, overlying the
skull, potentially suggestive of changes in epidermal fidel-
ity (Additional file 3: Figure S4, Additional file 4: Figure
S5). As Grhl3 and FGFR1 are co-expressed within the
overlying surface ectoderm, our future studies will further
investigate this relationship in the regulation of epidermal
development and function.
Lastly, we also investigated the expression of multiple
other factors, previously described as being involved in
suture closure and skull development (Noggin, Twist,
Runx2 and FGFR2), but could not discern any differ-
ences in expression of any of these, within the epidermis,
suture sites, calvaria outside the sutures or in the dermis.
Taken together with the lack of Grhl3 expression within
the suture site, brain or dermis, these data further sup-
porting our theory that closer apposition of the frontal
and parietal bones in our model is not caused by cell-
intrinsic defects within the cranial osteoblasts, but rather
is a secondary consequence of either ectodermal tension
or correct neural crest patterning, homing and fidelity.
Conclusions
Coronal craniosynostosis in humans presents with a
spectrum of severity and its aetiology is multifactorial
outside a narrow set of syndromes. We have shown by
Micro CT and histological techniques that genetic loss
of Grhl3 in our mouse model results in closer apposition
of the frontal and parietal bones, mimicking the early
stages of craniosynostosis which may cause significant
problems for the animal were it able to survive postna-
tally. The role of Grhl3, identification of binding part-
ners and interaction with downstream target genes
during development forms a promising avenue of inves-
tigation to help better understand the mechanisms by
which closer apposition of the frontal and parietal bones,
and possibly also coronal craniosynostosis, develops.
Additional files
Additional file 1: Figure S1. 3D rotating movies of representative E18.5
skulls. Representative movies allowing better visualisation of the skull
bones and coronal sutures in both WT (A) and Grhl3−/− (B) E18.5 embryos.
(ZIP 13 mb)
Additional file 2: Figure S3. Analysis of collagen deposition,
mineralisation and osteoblast alignment in E18.5 WT, Grhl3+/− and Grhl3−/−
skulls (A-C) Although collagen deposition in WT embryos appears more
advanced in E18.5 embryos c.f. E18.0 embryos (Verhoeff’s van Gieson’s stain),
organised collagen deposits are clearly visible in Grhl3+/− embryos (arrows),
and both are less pronounced than in Grhl3−/− embryos. (D-F) Masson’s
trichrome stain showing little difference in mineralisation between WT and
Grhl3+/− embryos. (G–I) Toluidine blue staining showing dark blue nuclei
(arrows in I) to define a clear row of osteoblasts along the emerging front in
Grhl3−/− embryos; there is little evidence of this in either WT or Grhl3+/−
embryos. (TIF 671 kb)
Additional file 3: Figure S4. Analysis of gene expression in the
developing coronal sutures of WT and Grhl3−/− embryos at E16.5 (A-B)
The expression of β-galactosidase (corresponding to the LacZ transgene
inserted within the Grhl3 locus, simultaneously disrupting gene function,
as well as acting as a reporter to confirm presence of the deleted allele [7])
was used to confirm loss of Grhl3. The expression of total FGFR1 (C-D),
pFGFR1 (E-F), FGFR2 (G-H), Twist (I-J), Runx2 (K-L) and Noggin (M-N) was
examined by immunohistochemical analysis. no significant differences
in the expression of any of these genes was detected, at E16.5 within
the calvaria, dura or suture regions. (ZIP 353 kb)
Additional file 4: Figure S5. Analysis of gene expression in the
developing coronal sutures of WT and Grhl3−/− embryos at E18.5. (A-B)
The expression of β-galactosidase (corresponding to the LacZ transgene
inserted within the Grhl3 locus, simultaneously disrupting gene function,
as well as acting as a reporter to confirm presence of the deleted allele
[7]) was used to confirm loss of Grhl3. The expression of total FGFR1 (C-D),
pFGFR1 (E-F), FGFR2 (G-H), Twist (I-J), Runx2 (K-L) and Noggin (M-N) was
examined by immunohistochemical analysis. Other than an apparent
loss of pFGFR1 in the most superficial layers of the surface ectoderm in
Grhl3−/− embryos at E18.5 (compare E with F; arrowheads), no significant
differences in the expression of any of these genes was detected at E18.5,
within the calvaria, dura or suture regions. (ZIP 362 kb)
Additional file 5: Figure S2. 3D rotating movies of representative adult
skulls. Representative movies allowing better visualisation of the skull
bones and coronal sutures in both WT (A) and Grhl3+/− (B) adult skulls.
(ZIP 2 mb)
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